Article
Vasopeptidase inhibition has potent effects on blood pressure and resistance arteries in stroke-prone spontaneously hypertensive rats.
Hypertension (Dallas, Tex. : 1979) - 1 Jun 2000
Intengan H D, Schiffrin E L
Abstract excerpt
The antihypertensive agent omapatrilat represents a novel approach to antihypertensive therapy, namely vasopeptidase inhibition. Omapatrilat (BMS-186716) concomitantly inhibits neutral endopeptidase and angiotensin-converting enzyme, leading to protection from degradation of natriuretic and other hypotensive peptides in addition to interruption of the renin-angiotensin system. Although the potency of omapatrilat...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
